Managing Patient and Clinician Expectations of Phage Therapy in the United Kingdom
Bacteriophage (phage) therapy is a promising alternative antimicrobial approach which has the potential to transform the way we treat bacterial infections. Phage therapy is currently being used on a compassionate basis in multiple countries. Therefore, if a patient has an antibiotic refractory infec...
| Những tác giả chính: | , , , , |
|---|---|
| Định dạng: | Bài viết |
| Ngôn ngữ: | English |
| Được phát hành: |
MDPI AG
2023-03-01
|
| Loạt: | Antibiotics |
| Những chủ đề: | |
| Truy cập trực tuyến: | https://www.mdpi.com/2079-6382/12/3/502 |
| _version_ | 1827751721172992000 |
|---|---|
| author | Joshua D. Jones Helen J. Stacey Arlene Brailey Mehrunisha Suleman Ross J. Langley |
| author_facet | Joshua D. Jones Helen J. Stacey Arlene Brailey Mehrunisha Suleman Ross J. Langley |
| author_sort | Joshua D. Jones |
| collection | DOAJ |
| description | Bacteriophage (phage) therapy is a promising alternative antimicrobial approach which has the potential to transform the way we treat bacterial infections. Phage therapy is currently being used on a compassionate basis in multiple countries. Therefore, if a patient has an antibiotic refractory infection, they may expect their clinician to consider and access phage therapy with the hope of improvement. The expectations of clinicians may be similar and may also include expectations around data collection. However, there are multiple biological and practical barriers to fulfilling patient and clinician expectations. While it is possible to access phage therapy, the path to acquisition is not straightforward and expectations therefore need to be managed appropriately to avoid raising false hope and undermining confidence in phage therapy. Phage scientists have an important contribution to make in educating clinicians and the broader public about phage therapy. However, it is clinicians that are responsible for managing the expectations of their patients and this relies on clear communication about the barriers and limitations. |
| first_indexed | 2024-03-11T07:02:06Z |
| format | Article |
| id | doaj.art-f59b4ab0a645428dbcb740f704fc860e |
| institution | Directory Open Access Journal |
| issn | 2079-6382 |
| language | English |
| last_indexed | 2024-03-11T07:02:06Z |
| publishDate | 2023-03-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Antibiotics |
| spelling | doaj.art-f59b4ab0a645428dbcb740f704fc860e2023-11-17T09:13:54ZengMDPI AGAntibiotics2079-63822023-03-0112350210.3390/antibiotics12030502Managing Patient and Clinician Expectations of Phage Therapy in the United KingdomJoshua D. Jones0Helen J. Stacey1Arlene Brailey2Mehrunisha Suleman3Ross J. Langley4Clinical Microbiology, Ninewells Hospital, NHS Tayside, Dundee DD2 1SG, UKPublic Health, Kings Cross Hospital, Clepington Road, Dundee DD3 8EA, UKAntibiotic Research UK, Genesis 5, York Science Park, Church Lane, Heslington, York YO10 5DQ, UKThe Ethox Centre, University of Oxford, Li Ka Shing Centre for Health Information and Discovery, Old Road Campus, Oxford OX3 7LF, UKDepartment of Paediatric Respiratory and Sleep Medicine, Royal Hospital for Children, 1345 Govan Road, Glasgow G51 4TF, UKBacteriophage (phage) therapy is a promising alternative antimicrobial approach which has the potential to transform the way we treat bacterial infections. Phage therapy is currently being used on a compassionate basis in multiple countries. Therefore, if a patient has an antibiotic refractory infection, they may expect their clinician to consider and access phage therapy with the hope of improvement. The expectations of clinicians may be similar and may also include expectations around data collection. However, there are multiple biological and practical barriers to fulfilling patient and clinician expectations. While it is possible to access phage therapy, the path to acquisition is not straightforward and expectations therefore need to be managed appropriately to avoid raising false hope and undermining confidence in phage therapy. Phage scientists have an important contribution to make in educating clinicians and the broader public about phage therapy. However, it is clinicians that are responsible for managing the expectations of their patients and this relies on clear communication about the barriers and limitations.https://www.mdpi.com/2079-6382/12/3/502bacteriophagephage therapypatientexpectationethicsUnited Kingdom |
| spellingShingle | Joshua D. Jones Helen J. Stacey Arlene Brailey Mehrunisha Suleman Ross J. Langley Managing Patient and Clinician Expectations of Phage Therapy in the United Kingdom Antibiotics bacteriophage phage therapy patient expectation ethics United Kingdom |
| title | Managing Patient and Clinician Expectations of Phage Therapy in the United Kingdom |
| title_full | Managing Patient and Clinician Expectations of Phage Therapy in the United Kingdom |
| title_fullStr | Managing Patient and Clinician Expectations of Phage Therapy in the United Kingdom |
| title_full_unstemmed | Managing Patient and Clinician Expectations of Phage Therapy in the United Kingdom |
| title_short | Managing Patient and Clinician Expectations of Phage Therapy in the United Kingdom |
| title_sort | managing patient and clinician expectations of phage therapy in the united kingdom |
| topic | bacteriophage phage therapy patient expectation ethics United Kingdom |
| url | https://www.mdpi.com/2079-6382/12/3/502 |
| work_keys_str_mv | AT joshuadjones managingpatientandclinicianexpectationsofphagetherapyintheunitedkingdom AT helenjstacey managingpatientandclinicianexpectationsofphagetherapyintheunitedkingdom AT arlenebrailey managingpatientandclinicianexpectationsofphagetherapyintheunitedkingdom AT mehrunishasuleman managingpatientandclinicianexpectationsofphagetherapyintheunitedkingdom AT rossjlangley managingpatientandclinicianexpectationsofphagetherapyintheunitedkingdom |